VLST cuts jobs to preserve cash, still feeding Novo Nordisk pipeline.

VLST has recently completed a round of layoffs. The company has eliminated about 30% of its workforce recently. The company had about 40 employees. On an as-needed basis, VLST evaluates its programmes and resources to make sure they are in alignment. Upon recently completing such an evaluation, the company restructured to best fit its current needs. VLST's restructuring was not focused on any group in particular. VLST's research group is heavily focused on its relationship with Novo Nordisk which has not changed. The cuts are surprising, given how VLST solidified its financial footing in 2008 when it signed the deal with Novo Nordisk. That deal brought in $12 M upfront to VLST, and Novo …